These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2561877)

  • 21. Dynamic MRI of hepatic tumors using gadolinium-DTPA--preliminary results.
    Ohtomo K; Yoshikawa K; Itai Y; Kokubo T; Yashiro N; Iio M
    Radiat Med; 1986; 4(2):51-3. PubMed ID: 3025941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic tumors: dynamic MR imaging.
    Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M; Furukawa K
    Radiology; 1987 Apr; 163(1):27-31. PubMed ID: 3029804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the maximum entropy method for evaluating phosphorus-31-magnetic resonance spectra in patients with liver metastases.
    Brinkmann G; Melchert UH; Dreher W; Brossmann J; Tressing H; Muhle C; Reuter M; Heller M
    Invest Radiol; 1995 Mar; 30(3):150-5. PubMed ID: 7797412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases.
    Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M
    Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
    Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
    J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Magnetic resonance tomography of focal liver lesions in comparison with computed tomography and sonography].
    Hamm B; Römer T; Friedrich M; Felix R; Wolf KJ
    Rofo; 1986 Mar; 144(3):278-86. PubMed ID: 3008228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRI and MRS in the diagnosis of cancer].
    Itai Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):639-45. PubMed ID: 2539787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate analysis of magnetic resonance imaging of focal hepatic lesions.
    Fujishima M; Suemitsu I; Sei T; Takeda Y; Hiraki Y
    Acta Med Okayama; 1993 Apr; 47(2):117-20. PubMed ID: 8389524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma and cavernous hemangioma: differentiation with MR imaging. Efficacy of T2 values at 0.35 and 1.5 T.
    Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Iio M
    Radiology; 1988 Sep; 168(3):621-3. PubMed ID: 2841716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma.
    Unal E; Francis F; Aquino A; Xu R; Morgan G; Teperman L
    Exp Clin Transplant; 2011 Oct; 9(5):344-8. PubMed ID: 21967263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MRI imaging of liver neoplasma].
    Mio A; Suzuki T; Suzaki K
    Rinsho Hoshasen; 1989 Dec; 34(13):1579-84. PubMed ID: 2560082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
    Liou J; Lee JK; Borrello JA; Brown JJ
    Magn Reson Imaging; 1994; 12(1):71-9. PubMed ID: 8295510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T.
    Choi BI; Han MC; Kim CW
    Radiology; 1990 Jul; 176(1):103-6. PubMed ID: 2162066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging.
    Li KC; Glazer GM; Quint LE; Francis IR; Aisen AM; Ensminger WD; Bookstein FL
    Radiology; 1988 Nov; 169(2):409-15. PubMed ID: 3174988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nuclear magnetic resonance imaging of liver masses].
    Ohtomo K; Araki T; Iio M
    Rinsho Hoshasen; 1983 Nov; 28(12):1461-4. PubMed ID: 6323793
    [No Abstract]   [Full Text] [Related]  

  • 36. Differentiation of hepatic cavernous hemangioma from metastases by rare sequence MR imaging.
    Jafari F; Nayeri N; Tahsini M; Khodadoust AA
    Magn Reson Imaging; 1999 Jun; 17(5):669-77. PubMed ID: 10372520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma.
    Yu JS; Kim KW; Park MS; Yoon SW
    J Comput Assist Tomogr; 2002; 26(3):411-7. PubMed ID: 12016371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.
    Bell JD; Cox IJ; Sargentoni J; Peden CJ; Menon DK; Foster CS; Watanapa P; Iles RA; Urenjak J
    Biochim Biophys Acta; 1993 Nov; 1225(1):71-7. PubMed ID: 8241291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical magnetic resonance spectroscopy of human breast disease.
    Merchant TE; Thelissen GR; de Graaf PW; Den Otter W; Glonek T
    Invest Radiol; 1991 Dec; 26(12):1053-9. PubMed ID: 1765437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
    Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
    Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.